Highly potent and specific siRNAs against E6 or E7 genes of HPV16-or HPV18-infected cervical cancers

Cancer Gene Therapy

Volumn 17, Issue 12, 2010, Pages 827-836

  Chang, J T C ^a,b   Kuo, T F ^b   Chen, Y J ^b   Chiu, C C ^b   Lu, Y C ^b   Li, H F ^b   Shen, C R ^b   Cheng, A J ^b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

cervical cancer; E6; E7; HPV; siRNA silencing

Indexed keywords

MESSENGER RNA; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL; CELL GROWTH; CLINICAL EFFECTIVENESS; COLONY FORMATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR XENOGRAFT; UTERINE CERVIX CANCER; VIRUS INFECTION; VIRUS ONCOGENE;

ANIMALS; CELL PROLIFERATION; DNA-BINDING PROTEINS; FEMALE; GENES, VIRAL; HELA CELLS; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS E7 PROTEINS; REPRESSOR PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; MUS MUSCULUS; PAPILLOMAVIRIDAE;

EID: 78349311997     PISSN: 09291903     EISSN: 14765500     Source Type: Journal    
DOI: 10.1038/cgt.2010.38     Document Type: Article

References (20)

1. Doorbar J. Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci 2006; 110: 525-541.
2. Goldie S. A public health approach to cervical cancer control: considerations of screening and vaccination strategies. Int J Gynecol Obstet 2006; 94: 95-105.
3. Munger K, Baldwin A, Edwards K, Hayakawa H, Nguyen C, Owens M et al. Mechanisms of human papillomavirus-induced oncogenesis. J Virol 2004; 78: 11451-11460.
4. Fehrmann F, Laimins L. Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation. Oncogene 2003; 22: 5201-5207.
5. Munger K, Howley P. Human papillomavirus immortalization and transformation functions. Virus Res 2002; 89: 213-228.
6. Snijders PJF, Steenbergen RDM, Heideman DAM, Meijer CJLM. HPV-mediated cervical carcinogenesis: concepts and clinical implications. J Pathol 2006; 208: 152-164.
7. Zaratiegui M, Irvine DV, Martienssen RA. Noncoding RNAs and gene silencing. Cell 2007; 128: 763-776.
8. Bayne EH, Allshire RC. RNA-directed transcriptional gene silencing in mammals. Trends Genet 2005; 21: 370-373.
9. Kim DH, Rossi JR. Strategies for silencing human disease using RNA interference. Genetics 2007; 8: 173-184.
10. Yamato K, Tamada T, Kizaki M, Ui-Tei K, Natori Y, Fujino M et al. New highly potent and specific E6 and E7 siRNAs for treatment of HPV16 positive cervical cancer. Cancer Gene Ther 2008; 15: 140-153.
11. Gu W, Putral L, Hengst K, Minto K, Saunders NA, Leggatt G et al. Inhibition of cervical cancer cell growth in vitro and in vivo with lentiviral-vector delivered short hairpin RNA targeting human papillomavirus E6 and E7 oncogenes. Cancer Gene Ther 2006; 13: 1023-1032.
12. Jiang M, Milner J. Selective silencing of viral gene E6 and E7 expression in HPV-positive human cervical carcinoma cells using small interfering RNAs. Methods Mol Biol 2005; 292: 401-420.
13. Jonson AL, Rogers LM, Ramakrishnan S, Downs Jr LS. Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention in a mouse model of cervical cancer. Gynecol Oncol 2008; 11: 356-364.
14. Lea JS, Sunaga N, Sato M, Kalahasti G, Miller DS, Minna JD et al. Silencing of HPV 18 oncoproteins with RNA interference causes growth inhibition of cervical cancer cells. Report Sci 2007; 14: 10-18.
15. Sima N, Wang W, Kong D, Deng D, Xu Q, Zhou J et al. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulationof Rb and 53. Apoptosis 2008; 13: 273-280.
16. Chiu CC, Lin CY, Lee LY, Chen YJ, Kuo TF, Chang JTC et al. Grp78 regulates multiple malignant phenotypes in head-neck cancer and may serve as a molecular target of therapeutic intervention. Mol Cancer Ther 2008; 7: 2788-2797.
17. Tseng CP, Huang CL, Huang CH, Cheng JC, Stem A, Tseng CH et al. Disabled-2 small interfering RNA modulates cellular adhesive function and MAPK activity during megakaryocytic differentiation of K562 cells. FEBS Lett 2003; 541: 21-27.
18. Chang JTC, Chan SH, Lin CY, Lin TY, Wang HM, Liao CT et al. Differentially expressed genes in radioresistant nasopharyngeal cancer cells: gp96 and GDF15. Mol Cancer Ther 2007; 6: 2271-2279.
19. DeFilippis RA, Goodwin EC, Wu L, DiMaio D. Endogenous human papillomavirus E6 and E7 Proteins differentially regulate proliferation, senescence, and apoptosis in HeLa cervical carcinoma cells. J Virol 2003; 77: 1551-1563.
20. Tang S, Tao M, McCoy Jr JP, Zheng ZM. The E7 oncoprotein is translated from spliced E6*I transcripts in high-risk human papillomavirus type 16-or type 18-positive cervical cancer cell lines via translation reinitiation. J Virol 2006; 80: 4249-4263.